MediciNova, Inc. (MNOV)

MediciNova Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	29.26	30.81	40.36	51	18.51	71.43
Short-Term Investments	-	-	-	-	39.98	-
Cash & Short-Term Investments	29.26	30.81	40.36	51	58.49	71.43
Cash Growth	-10.15%	-23.67%	-20.86%	-12.80%	-18.12%	18.98%
Prepaid Expenses	0.38	0.18	0.71	0.17	0.5	0.58
Total Current Assets	30.23	30.99	41.07	51.17	58.99	72.01
Property, Plant & Equipment	0.59	0.19	0.38	0.62	0.67	0.88
Goodwill	9.6	9.6	9.6	9.6	9.6	9.6
Other Intangible Assets	4.8	4.8	4.8	4.8	4.8	4.8
Other Long-Term Assets	0.02	0.02	0.02	0.07	0.09	0.12
Total Assets	45.24	45.6	55.88	66.27	74.15	87.41

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.9	0.62	1.1	1	0.42	0.4
Accrued Expenses	2.02	2.46	1.54	1.89	2.42	1.75
Current Portion of Leases	0.1	0.19	0.19	0.22	0.16	0.13
Current Unearned Revenue	0.43	0.37	-	-	-	-
Other Current Liabilities	-	0.15	0.13	0.16	0.18	0.55
Total Current Liabilities	3.46	3.8	2.96	3.28	3.19	2.83
Long-Term Leases	-	0.02	0.21	0.41	0.52	0.69
Long-Term Deferred Tax Liabilities	0.2	0.2	0.2	0.2	0.2	0.2
Other Long-Term Liabilities	0.49	-	-	-	-	-
Total Liabilities	4.15	4.02	3.37	3.89	3.91	3.73

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.05	0.05	0.05	0.05	0.05	0.05
Additional Paid-In Capital	487.66	480.41	479.34	478.15	477.44	476.79
Retained Earnings	-446.49	-438.75	-426.75	-415.7	-407.13	-393.06
Comprehensive Income & Other	-0.13	-0.13	-0.14	-0.12	-0.12	-0.1
Total Common Equity	41.09	41.59	52.5	62.38	70.24	83.68
Shareholders' Equity	41.09	41.59	52.5	62.38	70.24	83.68
Total Liabilities & Equity	45.24	45.6	55.88	66.27	74.15	87.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.1	0.21	0.41	0.63	0.68	0.83
Net Cash (Debt)	29.16	30.6	39.95	50.37	57.81	70.6
Net Cash Growth	-9.75%	-23.43%	-20.68%	-12.86%	-18.13%	17.97%
Net Cash Per Share	0.59	0.62	0.81	1.03	1.18	1.45
Filing Date Shares Outstanding	51.23	49.22	49.05	49.05	49.05	49.04
Total Common Shares Outstanding	51.23	49.22	49.05	49.05	49.05	49.04
Working Capital	26.78	27.19	38.12	47.9	55.8	69.18
Book Value Per Share	0.80	0.84	1.07	1.27	1.43	1.71
Tangible Book Value	26.69	27.19	38.1	47.98	55.84	69.28
Tangible Book Value Per Share	0.52	0.55	0.78	0.98	1.14	1.41
Machinery	-	0.09	0.09	0.13	0.12	0.12
Leasehold Improvements	-	-	-	0.01	0.01	0.02

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 12, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error